New insider activity at Abpro Holdings ( (ABP) ) has taken place on April 26, 2025.
CEO & Chairman Miles Suk Jin Wook has made a significant move by purchasing 34,002 shares of Abpro Holdings stock, valued at $11,113. This acquisition highlights his confidence in the company’s future prospects.
Recent Updates on ABP stock
Abpro Holdings has recently announced a delay in filing its Form 10-K for the fiscal year ending December 31, 2024, due to the need for additional time to prepare financial statements. The company does not expect significant changes in financial results from the previous year and plans to file within the allowed extension period. Additionally, Abpro Holdings revealed plans to present preclinical data for its investigational drug ABP-102/CT-P72 at an upcoming conference, highlighting its strategic partnership with Celltrion. This development underscores Abpro’s focus on advancing treatments for HER2+ cancers and reinforces its position in the biotechnology sector. Despite these announcements, the company’s year-to-date price performance remains significantly negative, although technical sentiment signals a ‘Buy’.
More about Abpro Holdings
YTD Price Performance: -78.92%
Average Trading Volume: 103,783
Technical Sentiment Signal: Buy
Current Market Cap: $17.28M